PCC Rokit (PCR) Q2 2025 earnings summary

Executive summary

• Consolidated revenue for 2024 was 1,947 million PLN, with EBITDA at 374 million PLN and net profit at 143 million PLN.

• In H1 2025, revenue declined 4.2% year-over-year to 958.1 million PLN, EBITDA fell 29% to 118.3 million PLN, and net profit dropped to 8.2 million PLN from 46.1 million PLN in H1 2024.

• Despite challenging market conditions, sales volume increased in H1 2025, supported by diversified product and client portfolios.

• The group operates in polyurethane, chlorinated derivatives, other chemicals, energy, and other services.

Financial highlights

• 2024 consolidated revenue: 1,947 million PLN; EBITDA: 374 million PLN; net profit: 143 million PLN.

• H1 2025 revenue: 958.1 million PLN (down 4.2% YoY); EBITDA: 118.3 million PLN (down 29% YoY); net profit: 8.2 million PLN (down 82% YoY).

• Operating profit for H1 2025 was 39.2 million PLN, down from 73.2 million PLN in H1 2024.

• Net cash flow in 2024 was -40 million PLN; in H1 2025, net cash flow was -76 million PLN.

• Total assets as of June 30, 2025, were 2.42 billion PLN, with equity at 1.3 billion PLN.

Outlook and guidance

• Ongoing investment projects in production capacity and innovation, including new lines for polyols and expansion of electrolysis facilities.

• Planned launch of new alkoxylation and electrolysis installations in 2026 to enhance product flexibility and reduce energy costs.

• Management notes ongoing adaptation to volatile market and supply chain conditions.